Paper3928803
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.
Herrmann F and 3 others. J Exp Med, 1985. Cited by 309 papers, by iCite.
Cite this record
ConductScience Library. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. Papers, record 3928803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3928803
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon-gamma | Major topic |
| Interleukin-2 | Major topic |
| Leukemia, Myeloid | Major topic |
| Monocytes | Major topic |
| Receptors, Immunologic | Major topic |
| Antibodies, Monoclonal | |
| Cell Differentiation | |
| Cell Division | |
| Cell Line | |
| Humans | |
| Receptors, Interleukin-2 | |
| T-Lymphocytes |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA19389 | NCI NIH HHS | United States | R01CA019389 | PubMed and NIH | NIH RePORTER |
| CA36167 | NCI NIH HHS | United States | R01CA036167 | PubMed and NIH | NIH RePORTER |
| R37CA036167 | NIH | NIH RePORTER |
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6970774 | A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. | J Immunol | 1981 | https://conductscience.org/library/papers/6970774 | PubMed |
| 2 | 6952949 | Isolation of myeloid progenitor cells from peripheral blood of chronic myelogenous leukemia patients. | Blood | 1982 | https://conductscience.org/library/papers/6952949 | PubMed |
| 3 | 6287286 | Prostaglandins modulate macrophage Ia expression. | Nature | 1982 | https://conductscience.org/library/papers/6287286 | PubMed |
| 4 | 6193183 | Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. | J Immunol | 1983 | https://conductscience.org/library/papers/6193183 | PubMed |
| 5 | 2578045 | Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. | J Immunol | 1985 | https://conductscience.org/library/papers/2578045 | PubMed |
| 6 | 6205075 | Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. | J Immunol | 1984 | https://conductscience.org/library/papers/6205075 | PubMed |
| 7 | 6092511 | Expression of interleukin 2 receptors on activated human B cells. | J Exp Med | 1984 | https://conductscience.org/library/papers/6092511 | PubMed |
| 8 | 6092512 | Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. | J Exp Med | 1984 | https://conductscience.org/library/papers/6092512 | PubMed |
| 9 | 3917277 | MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody. | J Immunol | 1985 | https://conductscience.org/library/papers/3917277 | PubMed |
| 10 | 6417261 | Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. | J Exp Med | 1983 | https://conductscience.org/library/papers/6417261 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 309 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353571 | In Vitro Effects of the Three Actives IL-12 (5 CH), IFN-γ (6 CH), and TNF-α (5 CH) from the Micro-Immunotherapy Medicine 2LEID-N® on Several Populations of Immune Cells. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42353571 | PubMed |
| 41514929 | Phenotypic Profiling and Activation-Associated Expression of CD99 Ligands on Human Leukocytes. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41514929 | PubMed |
| 40507248 | Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40507248 | PubMed |
| 40337274 | A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythematosus. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40337274 | PubMed |
| 32764489 | Therapeutic Zfra4-10 or WWOX7-21 Peptide Induces Complex Formation of WWOX with Selective Protein Targets in Organs that Leads to Cancer Suppression and Spleen Cytotoxic Memory Z Cell Activation In Vivo. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32764489 | PubMed |
| 27746745 | Pressure Induced Changes in Adaptive Immune Function in Belugas (Delphinapterus leucas); Implications for Dive Physiology and Health. | Front Physiol | 2016 | https://conductscience.org/library/papers/27746745 | PubMed |
| 26984209 | Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia. | Target Oncol | 2016 | https://conductscience.org/library/papers/26984209 | PubMed |
| 22530792 | Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes. | BMC Gastroenterol | 2012 | https://conductscience.org/library/papers/22530792 | PubMed |
| 18475735 | Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis. | Mediators Inflamm | 1996 | https://conductscience.org/library/papers/18475735 | PubMed |
| 18475504 | Suppression of monocyte and neutrophil function by recombinant IL-2. | Mediators Inflamm | 1993 | https://conductscience.org/library/papers/18475504 | PubMed |
| 18475497 | Biological significance of soluble IL-2 receptor. | Mediators Inflamm | 1993 | https://conductscience.org/library/papers/18475497 | PubMed |
| 17216565 | Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey. | J Clin Immunol | 2007 | https://conductscience.org/library/papers/17216565 | PubMed |
| 9685859 | Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C. | Jpn J Cancer Res | 1998 | https://conductscience.org/library/papers/9685859 | PubMed |
| 8878609 | Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8878609 | PubMed |
| 8755561 | An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8755561 | PubMed |
| 8698622 | Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8698622 | PubMed |
| 8645743 | LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells. | Ann Hematol | 1996 | https://conductscience.org/library/papers/8645743 | PubMed |
| 8311539 | Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. | Ann Rheum Dis | 1993 | https://conductscience.org/library/papers/8311539 | PubMed |
| 8039809 | Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. | Immunology | 1994 | https://conductscience.org/library/papers/8039809 | PubMed |
| 8003557 | Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatment. | Ann Hematol | 1994 | https://conductscience.org/library/papers/8003557 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3928803
GET https://conductscience.org/api/papers/v1/3928803/cited_by?page=2